0001493152-16-006985.txt : 20160127
0001493152-16-006985.hdr.sgml : 20160127
20160127162634
ACCESSION NUMBER: 0001493152-16-006985
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160127
DATE AS OF CHANGE: 20160127
EFFECTIVENESS DATE: 20160127
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: SignPath Pharma, Inc.
CENTRAL INDEX KEY: 0001455694
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205079533
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-229174
FILM NUMBER: 161365332
BUSINESS ADDRESS:
STREET 1: 3477 CORPORATE PARKWAY, SUITE 100
CITY: CENTER VALLEY
STATE: PA
ZIP: 18034
BUSINESS PHONE: 215-538-9996
MAIL ADDRESS:
STREET 1: 3477 CORPORATE PARKWAY, SUITE 100
CITY: CENTER VALLEY
STATE: PA
ZIP: 18034
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001455694
SignPath Pharma, Inc.
3477 CORPORATE PARKWAY, SUITE 100
CENTER VALLEY
PA
PENNSYLVANIA
18034
215-538-9996
DELAWARE
None
None
Corporation
true
Lawrence
D.
Helson
3477 Corporate Parkway, Suite 100
Center Valley
PA
PENNSYLVANIA
18034
Executive Officer
Director
CEO, President and Director
Arthur
P.
Bollon, Ph.D
3477 Corporate Parkway, Suite 100
Center Valley
PA
PENNSYLVANIA
18034
Director
Jack
Levine, CPA
3477 Corporate Parkway, Suite 100
Center Valley
PA
PENNSYLVANIA
18034
Director
None
Meyers Associates, L.P.
45 Broadway
2nd Floor
New York
NY
NEW YORK
10006
Promoter
Pharmaceuticals
Decline to Disclose
- 06b
true
0001144204-14-071232
2014-10-31
false
true
true
false
100000
Meyers Associates, L.P.
34171
Bruce Meyers
1045447
45 BROADWAY
2ND FLOOR
NEW YORK
NY
NEW YORK
1006
All States
false
3000000
2359076
640924
The Offering was terminated on January 26, 2016 and raised $2,359,076 from thirty-six investors.
false
36
235908
0
Meyers Associates, L.Ps., will receive a 10% commission and warrants to purchase up to 20% of the Units sold in this offering.
204000
$204,000 towards CEO's salary.
false
SignPath Pharma, Inc.
/s/ Lawrence D. Helson
Lawrence D. Helson
CEO & President
2016-01-27